Morsua, Jaime M.
HRN: 14-74-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/09/2024
01/15/2024
IV
1.5g
Q8
CAP-MR; Pleural Effusion
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes